floatz AI vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

Dimensionfloatz AIIsomorphic Labs
PricingContact (custom quote)Contact (partnership only, no per-use pricing)
Target UserDrug discovery scientists, biotech R&D teams, academic labsLarge pharma companies seeking deep partnerships
Core TechnologyAI-driven target identification & prioritization from multi-omics dataAlphaFold-based predictive and generative models for drug design
Best ForEarly-stage target discovery with transparent, exportable resultsLarge-scale lead optimization through pharma collaborations
Not ForTeams needing clinical trial management or individual students without institutional accessIndividual researchers, startups, or projects needing ready-to-use API or low-cost access
Recent NewsNo recent news capturedSeries B (2026-05-12), J&J collaboration (2026-01-20), $600M funding (2025-03-31)

Choose floatz AI if you need an affordable, self-serve platform for early-stage target discovery with multi-omics integration and exportable reports. Choose Isomorphic Labs only if you are a large pharma company seeking a high-investment, collaborative AI partnership leveraging AlphaFold for lead optimization. For most biotech and academic teams without deep pharma backing, floatz AI is the more accessible and practical choice.

floatz AI
floatz AI

AI-driven scientific diligence for pharma, biotech, and investment decisions.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
2 views
7.4k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
Categories
🧬 Drug Discovery & Life Sciences🔬 Research & Education🧮 Business Intelligence
🧬 Drug Discovery & Life Sciences
Features
Self-learning AI agents for deep science search
Expert-level reasoning on therapeutic assets
Life science knowledge graph linking findings and claims
Living reports for interactive evidence exploration
Claim-to-source referencing in every report
Evidence gap detection for deal diligence
Portfolio-level standardization across candidates
Development risk identification before in-licensing
Benchmark candidates against their competitive class
Surface insights beyond the data room
Support for pharma, biotech, and investor workflows
AI-driven scientific diligence for M&A and investment
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: floatz AI vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

floatz AI

0 mentions · mixed

What users praise

  • Focuses exclusively on early-stage target discovery, reducing noise.
  • Integrates multiple omics data types for holistic predictions.
  • Intuitive interface lowers barrier for non-computational scientists.
  • Quarterly model updates reflect latest biological findings.

What frustrates them

  • No community feedback to validate real-world utility.
  • Pricing is opaque (contact-only), creating budget uncertainty.
  • Lacks integrations with popular lab informatics tools.
  • Performance claims are unbacked by public benchmarks.

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Biotech R&D Scientist at a startup
    Pick: floatz AI

    Access to multi-omics target identification, custom model training, and exportable reports fits the self-serve, budget-conscious needs of a startup.

  • Academic pharmacology lab
    Pick: floatz AI

    Collaborative workspaces and integration with public databases enable research without needing pharma partnerships.

  • Large pharma drug discovery team (lead optimization)
    Pick: Isomorphic Labs

    AlphaFold-based predictive and generative models, plus deep collaboration, are ideal for complex, large-scale programs.

  • Computational biologist seeking target validation tools
    Pick: floatz AI

    Literature mining and target-disease visualization provide hands-on validation evidence.

  • Pharma company with late-stage pipeline
    Pick: Isomorphic Labs

    Partnership model and digital biology simulation accelerate lead optimization, but require significant investment.

Frequently Asked Questions

floatz AI vs Isomorphic Labs: which should you choose?

Choose floatz AI if you need an affordable, self-serve platform for early-stage target discovery with multi-omics integration and exportable reports. Choose Isomorphic Labs only if you are a large pharma company seeking a high-investment, collaborative AI partnership leveraging AlphaFold for lead optimization. For most biotech and academic teams without deep pharma backing, floatz AI is the more accessible and practical choice.

Can I use Isomorphic Labs directly as a software tool?

No, Isomorphic Labs operates only through deep pharma partnerships; it does not offer a ready-to-use API or software platform.

Does floatz AI support custom data uploads?

Yes, floatz AI allows custom model training on user-uploaded datasets.

Is Isomorphic Labs based on AlphaFold?

Yes, it builds on the Nobel Prize-winning AlphaFold for protein structure prediction and drug design.

What integrations does floatz AI have?

It integrates with public biomedical databases like ChEMBL and DisGeNET, and offers API access.

Which tool is better for academic researchers?

Floatz AI is better for academics due to its collaborative workspace, exportable reports, and lack of partnership requirements.

Is off-target prediction available in floatz AI?

Yes, floatz AI includes off-target prediction and toxicity estimation.

Has Isomorphic Labs announced any recent funding?

Yes, Isomorphic Labs raised $600M external investment in 2025 and a Series B in 2026.

Can I get a free trial of either tool?

Neither tool offers free trials publicly; both require contacting sales for pricing and access.

More floatz AI or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026